Q85.83
Von Hippel-Lindau syndrome
Clinical Classification Guidelines
Code Also
- manifestations
Medical Intelligence & Overview
Von Hippel-Lindau (VHL) syndrome is a rare genetic disorder characterized by the development of tumors and cysts in different parts of the body. It is caused by mutations in the VHL gene, which plays a role in controlling cell growth and blood vessel formation. This condition can affect various organs, including the eyes, brain, spine, kidneys, pancreas, and adrenal glands. Early diagnosis and management are crucial to monitor tumor development and prevent serious complications.
Causes & Symptoms
Clinical Causes: Inherited genetic mutation in the VHL gene Autosomal dominant inheritance pattern, meaning only one copy of the mutated gene is sufficient to cause the disorder A family history of VHL syndrome increases the risk
Key Symptoms: Hemangioblastomas (blood vessel tumors) in the brain and spinal cord, which may cause headaches, balance issues, or neurological problems Retinal hemangioblastomas affecting vision Kidney tumors, which can be benign or malignant, potentially leading to kidney failure Adrenal gland tumors (pheochromocytomas) that may cause high blood pressure, sweating, or rapid heartbeat Cysts and tumors in the pancreas, sometimes causing abdominal pain or digestive issues Other possible symptoms include ringing in the ears, dizziness, or unexplained weight loss depending on tumor locations
Diagnostic & Treatment
Diagnosis Path: Diagnosis of VHL syndrome typically involves a combination of clinical examinations, imaging tests, and genetic analysis. These include:
Treatment Protocols: Managing VHL syndrome focuses on monitoring and treating tumors early to prevent complications. Treatment options may include:
Clinical Advice & FAQs
Billing Guidance
Is Q85.83 a billable ICD-10 code?
Yes, Q85.83 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q85.83?
Clinical documentation must specify the nature of Von Hippel-Lindau syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference